Compare PROF & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | QUIK |
|---|---|---|
| Founded | N/A | 1988 |
| Country | Canada | United States |
| Employees | N/A | 51 |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.2M | 211.8M |
| IPO Year | 2017 | 1997 |
| Metric | PROF | QUIK |
|---|---|---|
| Price | $6.46 | $21.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $11.00 |
| AVG Volume (30 Days) | 65.9K | ★ 689.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $16,098,000.00 | ★ $20,112,000.00 |
| Revenue This Year | $92.40 | $75.17 |
| Revenue Next Year | $64.10 | $16.04 |
| P/E Ratio | $35.11 | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $4.80 |
| 52 Week High | $8.95 | $23.80 |
| Indicator | PROF | QUIK |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 61.08 |
| Support Level | $5.81 | $5.92 |
| Resistance Level | $7.07 | $23.24 |
| Average True Range (ATR) | 0.27 | 1.84 |
| MACD | -0.07 | -0.19 |
| Stochastic Oscillator | 15.15 | 67.38 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.